drugset / Trial / NCT03139422
Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss
RandomizedParallel-groupOpen-labelTreatment
Summary
Intrauterine contraceptive device is the most commonly reversible method used among women of reproductive age worldwide. Almost one in five married contraceptive users is currently using Intrauterine contraceptive device. The Egyptian demographic and health survey results indicate that 30% of currently married women interviewed in the Egyptian demographic and health survey were using Intrauterine contraceptive device. Main reasons for discontinuation of Intrauterine contraceptive device as cited by women were excessive bleeding per vagina 39.68%, abdominal pain 38.62%, low backache35.97%.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2018-10
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcium Dobesilate | Unknown | 500 mg | Oral |
| Comparator | Tranexamic Acid | Small molecule | 500 mg | Oral |